BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29749467)

  • 1. KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells.
    Kawai Y; Shibata K; Sakata J; Suzuki S; Utsumi F; Niimi K; Sekiya R; Senga T; Kikkawa F; Kajiyama H
    Oncol Rep; 2018 Jul; 40(1):195-205. PubMed ID: 29749467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
    Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
    IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
    Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
    PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells.
    Li Y; Guo H; Wang Z; Bu H; Wang S; Wang H; Fang H; Liu Z; Kong B
    Exp Cell Res; 2020 Oct; 395(2):112212. PubMed ID: 32771525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome.
    Ren X; Chen X; Ji Y; Li L; Li Y; Qin C; Fang K
    Aging (Albany NY); 2020 Nov; 12(24):25878-25894. PubMed ID: 33232285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma.
    Shimbo A; Kajiyama H; Tamauchi S; Yoshikawa N; Ikeda Y; Nishino K; Suzuki S; Niimi K; Sakata J; Kikkawa F
    Oncol Rep; 2019 Dec; 42(6):2323-2332. PubMed ID: 31578579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist expression predicts poor clinical outcome of patients with clear cell carcinoma of the ovary.
    Kajiyama H; Hosono S; Terauchi M; Shibata K; Ino K; Yamamoto E; Nomura S; Nawa A; Kikkawa F
    Oncology; 2006; 71(5-6):394-401. PubMed ID: 17690559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
    Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
    Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
    Davidson B; Trope' CG; Wang TL; Shih IeM
    Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.
    Itamochi H; Oumi N; Oishi T; Taniguchi F; Shoji T; Fujiwara H; Sugiyama T; Suzuki M; Kigawa J; Harada T
    Int J Gynecol Cancer; 2015 May; 25(4):570-6. PubMed ID: 25756405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
    Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
    Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
    Higashi M; Kajiyama H; Shibata K; Mizuno M; Mizuno K; Hosono S; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Gynecol Oncol; 2011 Dec; 123(3):474-8. PubMed ID: 21955484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer.
    Nakamura M; Takano A; Thang PM; Tsevegjav B; Zhu M; Yokose T; Yamashita T; Miyagi Y; Daigo Y
    Int J Oncol; 2020 Jul; 57(1):277-288. PubMed ID: 32467984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
    Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
    J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary.
    Miyamoto M; Takano M; Iwaya K; Shinomiya N; Kato M; Aoyama T; Sasaki N; Goto T; Suzuki A; Hitrata J; Furuya K
    Br J Cancer; 2014 Jun; 110(12):2881-6. PubMed ID: 24853184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
    Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
    BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIF20A, highly expressed in immature hematopoietic cells, supports the growth of HL60 cell line.
    Morita H; Matsuoka A; Kida JI; Tabata H; Tohyama K; Tohyama Y
    Int J Hematol; 2018 Dec; 108(6):607-614. PubMed ID: 30182171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
    Li M; Li H; Liu F; Bi R; Tu X; Chen L; Ye S; Cheng X
    J Ovarian Res; 2017 Feb; 10(1):9. PubMed ID: 28187748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.